137 related articles for article (PubMed ID: 31401297)
1. How tenofovir disoproxil fumarate can impact on solubility and dissolution rate of efavirenz?
Bazzo GC; Mostafa D; França MT; Pezzini BR; Stulzer HK
Int J Pharm; 2019 Oct; 570():118597. PubMed ID: 31401297
[TBL] [Abstract][Full Text] [Related]
2. Fusion Method for Solubility and Dissolution Rate Enhancement of Ibuprofen Using Block Copolymer Poloxamer 407.
Dugar RP; Gajera BY; Dave RH
AAPS PharmSciTech; 2016 Dec; 17(6):1428-1440. PubMed ID: 26817763
[TBL] [Abstract][Full Text] [Related]
3. Crystal Structure Analysis of the First Discovered Stability-Enhanced Solid State of Tenofovir Disoproxil Free Base Using Single Crystal X-ray Diffraction.
An JH; Kiyonga AN; Yoon W; Ryu HC; Kim JS; Kang C; Park M; Yun H; Jung K
Molecules; 2017 Jul; 22(7):. PubMed ID: 28708115
[TBL] [Abstract][Full Text] [Related]
4. Development of novel tenofovir disoproxil phosphate salt with stability enhancement and bioequivalence to the commercial tenofovir disoproxil fumarate salt in rats and beagle dogs.
Cho JH; Choi HG
Int J Pharm; 2020 Feb; 576():118957. PubMed ID: 31843551
[TBL] [Abstract][Full Text] [Related]
5. Multicomponent systems with cyclodextrins and hydrophilic polymers for the delivery of Efavirenz.
Vieira AC; Ferreira Fontes DA; Chaves LL; Alves LD; de Freitas Neto JL; de La Roca Soares MF; Soares-Sobrinho JL; Rolim LA; Rolim-Neto PJ
Carbohydr Polym; 2015 Oct; 130():133-40. PubMed ID: 26076609
[TBL] [Abstract][Full Text] [Related]
6. Engineering of a hybrid polymer-lipid nanocarrier for the nasal delivery of tenofovir disoproxil fumarate: physicochemical, molecular, microstructural, and stability evaluation.
Pokharkar VB; Jolly MR; Kumbhar DD
Eur J Pharm Sci; 2015 Apr; 71():99-111. PubMed ID: 25708940
[TBL] [Abstract][Full Text] [Related]
7. Organic vapor sorption method of isostructural solvates and polymorph of tenofovir disoproxil fumarate.
Lee J; Boerrigter SX; Jung YW; Byun Y; Yuk SH; Byrn SR; Lee EH
Eur J Pharm Sci; 2013 Nov; 50(3-4):253-62. PubMed ID: 23872626
[TBL] [Abstract][Full Text] [Related]
8. Antisolvent precipitation technique: A very promising approach to crystallize curcumin in presence of polyvinyl pyrrolidon for solubility and dissolution enhancement.
Sadeghi F; Ashofteh M; Homayouni A; Abbaspour M; Nokhodchi A; Garekani HA
Colloids Surf B Biointerfaces; 2016 Nov; 147():258-264. PubMed ID: 27518458
[TBL] [Abstract][Full Text] [Related]
9. Solubility and dissolution enhancement of efavirenz hot melt extruded amorphous solid dispersions using combination of polymeric blends: A QbD approach.
Pawar J; Tayade A; Gangurde A; Moravkar K; Amin P
Eur J Pharm Sci; 2016 Jun; 88():37-49. PubMed ID: 27049050
[TBL] [Abstract][Full Text] [Related]
10. Study the influence of formulation process parameters on solubility and dissolution enhancement of efavirenz solid solutions prepared by hot-melt extrusion: a QbD methodology.
Pawar J; Suryawanshi D; Moravkar K; Aware R; Shetty V; Maniruzzaman M; Amin P
Drug Deliv Transl Res; 2018 Dec; 8(6):1644-1657. PubMed ID: 29426975
[TBL] [Abstract][Full Text] [Related]
11. Cyclodextrin inclusion complex of racecadotril: effect of drug-β- cyclodextrin ratio and the method of complexation.
Semalty M; Panchpuri M; Singh D; Semalty A
Curr Drug Discov Technol; 2014 Jun; 11(2):154-61. PubMed ID: 24188445
[TBL] [Abstract][Full Text] [Related]
12. Preparation and characterization of glimepiride eutectic mixture with l-arginine for improvement of dissolution rate.
Park H; Seo HJ; Ha ES; Hong SH; Kim JS; Kim MS; Hwang SJ
Int J Pharm; 2020 May; 581():119288. PubMed ID: 32243966
[TBL] [Abstract][Full Text] [Related]
13. Dissolution, solubility, XRD, and DSC studies on flurbiprofen-nicotinamide solid dispersions.
Varma MM; Pandi JK
Drug Dev Ind Pharm; 2005 May; 31(4-5):417-23. PubMed ID: 16093207
[TBL] [Abstract][Full Text] [Related]
14. Quantitative determination of two polymorphic forms of imatinib mesylate in a drug substance and tablet formulation by X-ray powder diffraction, differential scanning calorimetry and attenuated total reflectance Fourier transform infrared spectroscopy.
Bellur Atici E; Karlığa B
J Pharm Biomed Anal; 2015 Oct; 114():330-40. PubMed ID: 26099262
[TBL] [Abstract][Full Text] [Related]
15. An Approach to Enhance Dissolution Rate of Tamoxifen Citrate.
SreeHarsha N; Hiremath JG; Chilukuri S; Aitha RK; Al-Dhubiab BE; Venugopala KN; Alzahrani AM; Meravanige G
Biomed Res Int; 2019; 2019():2161348. PubMed ID: 30800663
[TBL] [Abstract][Full Text] [Related]
16. A New Extrudable Form of Hypromellose: AFFINISOL™ HPMC HME.
Huang S; O'Donnell KP; Keen JM; Rickard MA; McGinity JW; Williams RO
AAPS PharmSciTech; 2016 Feb; 17(1):106-19. PubMed ID: 26335416
[TBL] [Abstract][Full Text] [Related]
17. Physicochemical characterization and dissolution study of solid dispersions of ketoconazole with nicotinamide.
Aggarwal AK; Jain S
Chem Pharm Bull (Tokyo); 2011; 59(5):629-38. PubMed ID: 21532202
[TBL] [Abstract][Full Text] [Related]
18. Study on Enhanced Dissolution of Azilsartan-Loaded Solid Dispersion, Prepared by Combining Wet Milling and Spray-Drying Technologies.
Lu T; Sun Y; Ding D; Zhang Q; Fan R; He Z; Wang J
AAPS PharmSciTech; 2017 Feb; 18(2):473-480. PubMed ID: 27116201
[TBL] [Abstract][Full Text] [Related]
19. Improved Aqueous Solubility and Antihypercholesterolemic Activity of Ezetimibe on Formulating with Hydroxypropyl-β-Cyclodextrin and Hydrophilic Auxiliary Substances.
Srivalli KM; Mishra B
AAPS PharmSciTech; 2016 Apr; 17(2):272-83. PubMed ID: 26077622
[TBL] [Abstract][Full Text] [Related]
20. Improvement in oral bioavailability and dissolution of tanshinone IIA by preparation of solid dispersions with porous silica.
Yan HM; Sun E; Cui L; Jia XB; Jin X
J Pharm Pharmacol; 2015 Sep; 67(9):1207-14. PubMed ID: 25944009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
